Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling

Cardiovascular Research
Sirirat SurinkaewStanley Nattel

Abstract

Heart failure (HF) produces left atrial (LA)-selective fibrosis and promotes atrial fibrillation. HF also causes adrenergic activation, which contributes to remodelling via a variety of signalling molecules, including the exchange protein activated by cAMP (Epac). Here, we evaluate the effects of Epac1-signalling on LA fibroblast (FB) function and its potential role in HF-related atrial remodelling. HF was induced in adult male mongrel dogs by ventricular tachypacing (VTP). Epac1-expression decreased in LA-FBs within 12 h (-3.9-fold) of VTP onset. The selective Epac activator, 8-pCPT (50 µM) reduced, whereas the Epac blocker ESI-09 (1 µM) enhanced, collagen expression in LA-FBs. Norepinephrine (1 µM) decreased Epac1-expression, an effect blocked by prazosin, and increased FB collagen production. The β-adrenoceptor (AR) agonist isoproterenol increased Epac1 expression, an effect antagonized by ICI (β2-AR-blocker), but not by CGP (β1-AR-blocker). β-AR-activation with isoproterenol decreased collagen expression, an effect mimicked by the β2-AR-agonist salbutamol and blocked by the Epac1-antagonist ESI-09. Transforming growth factor-β1, known to be activated in HF, suppressed Epac1 expression, an effect blocked by the Smad3-inhibit...Continue Reading

References

Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Aug 1, 1995·The Journal of Clinical Investigation·W A Border, N A Noble
Jul 1, 1994·Journal of Molecular and Cellular Cardiology·C G BrillaK T Weber
Dec 18, 1998·Science·H KawasakiA M Graybiel
Jan 25, 2000·American Journal of Physiology. Cell Physiology·J G MeszarosL L Brunton
Sep 16, 2000·Hypertension·R K DubeyE K Jackson
Dec 29, 2004·Cardiovascular Research·Patrizia CamellitiPeter Kohl
Dec 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·James S SwaneyPaul A Insel
Apr 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Troy A BaudinoThomas K Borg
Oct 3, 2006·Cellular and Molecular Life Sciences : CMLS·H Lim, Y Z Zhu
Nov 7, 2006·Trends in Biochemical Sciences·Johannes L Bos
Feb 26, 2008·Journal of the American College of Cardiology·Brett Burstein, Stanley Nattel
Mar 8, 2008·Circulation Research·Mélanie MétrichFrank Lezoualc'h
Apr 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Utako YokoyamaPaul A Insel
Mar 13, 2009·American Journal of Physiology. Cell Physiology·Francisco VillarrealLaurence L Brunton
May 23, 2009·Pharmacology & Therapeutics·Karen E Porter, Neil A Turner
Oct 31, 2009·Journal of the American College of Cardiology·Filippos TriposkiadisJaved Butler
Nov 17, 2009·British Journal of Pharmacology·Maria GrandochMartina Schmidt
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Martijn Gloerich, Johannes L Bos
Jul 20, 2010·Biochimica Et Biophysica Acta·Pablo Aránguiz-UrrozGuillermo Díaz-Araya
Mar 16, 2011·Cellular Signalling·Magali BrecklerFrank Lezoualc'h
Jan 12, 2012·British Journal of Pharmacology·Paul A InselNakon Aroonsakool
Oct 30, 2012·Circulation Research·Xiaoying ZhangXiongwen Chen
Jul 13, 2013·Toxicology and Applied Pharmacology·Ivonne OlmedoGuillermo Díaz-Araya
Aug 31, 2013·Circulation Research·Anastasios LymperopoulosWalter J Koch
May 9, 2014·Cardiovascular Research·Nataliya DybkovaLars S Maier
Jun 4, 2014·The Journal of Clinical Investigation·Satoshi OkumuraYoshihiro Ishikawa
Nov 21, 2014·Cardiovascular Research·Anne-Coline LaurentFrank Lezoualc'h
Feb 9, 2016·Canadian Journal of Physiology and Pharmacology·Yan YangJun Li
Mar 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Pooja SinghmarAnnemieke Kavelaars
Mar 5, 2016·Circulation Research·Frank Lezoualc'hCaroline Conte
Aug 24, 2016·Cellular and Molecular Life Sciences : CMLS·Takayuki FujitaYoshihiro Ishikawa
Jan 18, 2017·Circulation Research·Loubina FazalFrank Lezoualc'h

❮ Previous
Next ❯

Citations

Dec 7, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Rajesh PrajapatiYoshihiro Ishikawa
Oct 26, 2018·Cardiovascular Research·Laetitia Pereira
Jan 1, 2020·Cells·Marion DelaunayDario Diviani
Mar 23, 2019·International Journal of Molecular Sciences·Celina M PollardAnastasios Lymperopoulos
Mar 7, 2021·Molecular Biology Reports·Yaqian Wang, Shujuan Jiang
Mar 27, 2021·European Journal of Pharmacology·Jin-Xing ZhuMei-Ping Wu
May 1, 2021·Cells·Anne-Sophie Colombe, Guillaume Pidoux
Oct 27, 2021·Physiological Reviews·Katrina F OstromRennolds S Ostrom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2022 Meta ULC. All rights reserved